5ZB-17334-15070 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Dose 1 — Moderna
2021-04-01
Dose 2 — Moderna
2021-11-11
Dose 3 — Moderna
2022-04-08
Dose 4 — Moderna
2022-04-29
Registered in v-safe
2022-04-29
Survey response — day 21, dose 4
MedDRA: Hypoaesthesia, Neuropathy peripheral, Pain, Paraesthesia — Feeling: Fair · Be unable to do your normal daily activities

Free text: On April 11, 2022, three days after my fourth shot, I began experiencing peripheral neuropathy symptoms in both feet, and slightly, in fingers. These symptoms (numbness, tingling, mild pain) have persisted for nearly three weeks, with no improvement.

MedDRA releases: 2024-11 · check-in free text available
2022-05-06
Health check-in — day 28, dose 4
Feeling: Fair

Adult check-in
2022-05-15
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-05-20
Health check-in — day 42, dose 4
Feeling: Fair

Adult check-in
2022-07-08
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2022-10-07
Survey response — 6 months, dose 4
MedDRA: Hypoaesthesia, Paraesthesia — Feeling: Good · Be unable to do your normal daily activities

Free text: For several days I experienced symptoms of peripheral neuropathy (numbness and tingling) in both feet. These side effects are identical to ones after my last booster shot in April 2022, although they do seem to be lessening sooner.

MedDRA releases: 2024-11 · check-in free text available
2023-04-10
Health check-in — 12 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-04	Moderna	No
2	2021-04-01	Moderna	No
3	2021-11-11	Moderna	No
4	2022-04-08	Moderna	No

Free text

Release 11 — day 21, dose 4

2022-04-29

Symptoms: On April 11, 2022, three days after my fourth shot, I began experiencing peripheral neuropathy symptoms in both feet, and slightly, in fingers. These symptoms (numbness, tingling, mild pain) have persisted for nearly three weeks, with no improvement. cut off by CDC

Release 12 — 6 months, dose 4

2022-10-07

Symptoms: For several days I experienced symptoms of peripheral neuropathy (numbness and tingling) in both feet. These side effects are identical to ones after my last booster shot in April 2022, although they do seem to be lessening sooner.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Hypoaesthesia	·	·	✓
SD	Neuropathy peripheral	·	·	✓
SD	Pain	·	·	✓
SD	Paraesthesia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release